HLB Pharma Decides to Acquire Stocks Worth 12.1 Billion KRW from US Pharmaceutical Company
[Asia Economy Reporter Park Jun-yi] HLB Pharmaceutical announced on the 6th that it has decided to acquire 3,187,962 shares of stock worth approximately 12.13837 billion KRW from its affiliate, the US-based Verismo Therapeutics, with the aim of maximizing corporate value. This corresponds to 15.49% of its equity capital.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
